Other Clinical Trial - Genotypic & Phenotypic Correlates of Resistance to

Clinical Trial Description

Not desired ;

Study Design

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Related Conditions & MeSH terms

Blood Platelet Disorders
Platelet Dysfunction Due to Aspirin

See also
	Status	Clinical Trial	Phase
	Recruiting	`NCT03255928` - Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)
	Completed	`NCT05604118` - Platelet Enzymatically Oxidized Phospholipids (eoxPL) Characterisation in a Healthy Cohort on and Off Aspirin	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT03255928 - Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD)

Completed

NCT05604118 - Platelet Enzymatically Oxidized Phospholipids (eoxPL) Characterisation in a Healthy Cohort on and Off Aspirin

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT01361620
Study type	Interventional
Source	George Washington University
Contact
Status	Completed
Phase	N/A
Start date	December 2007
Completion date	April 2011

Genotypic and Phenotypic Correlates of Resistance to Aspirin — ARSENAL

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms